The estimated Net Worth of Hove Caroline F. Van is at least 68.7 千$ dollars as of 10 November 2021. Ms. Van owns over 6,087 units of Sientra Inc stock worth over 24,942$ and over the last 5 years she sold SIEN stock worth over 43,806$. In addition, she makes 0$ as Independent Director at Sientra Inc.
Sign up
Ms. Hove SIEN stock SEC Form 4 insiders trading
Caroline has made over 2 trades of the Sientra Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 6,087 units of SIEN stock worth 34,513$ on 10 November 2021.
The largest trade she's ever made was selling 6,087 units of Sientra Inc stock on 10 November 2021 worth over 34,513$. On average, Caroline trades about 672 units every 25 days since 2020. As of 10 November 2021 she still owns at least 146,720 units of Sientra Inc stock.
You can see the complete history of Ms. Van stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Caroline Van Hove biography
Caroline Van Hove serves as Independent Director of the Company. Ms. Van Hove has served as a director of the Company since January 2020. Ms. Van Hove is a global commercial leader with over 20 years of diverse experience in the pharmaceutical, consumer, and medical device industry. Her experience spans North America to Europe, Africa, the Middle East to Asia Pacific and Latin America. Ms. Van Hove most recently served as Chief Commercial Officer of Sienna Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on therapies in immunology and inflammation, from March 2018 until 2019. Prior to Sienna, Ms. Van Hose served in a number of roles at Allergan from 1992 to 2018, most recently as Senior Vice President of the International Strategic Marketing, where she oversaw commercial operations for the medical aesthetics, eye care and specialty care franchises, and, previously, managing commercial operations in Europe, Africa and the Middle East, and led Allergan’s international medical aesthetics operations and serving as part of Allergan’s Global Operations and International Leadership Teams.
How old is Caroline Hove?
Caroline Hove is 40, she's been the Independent Director of Sientra Inc since 2020. There are 7 older and no younger executives at Sientra Inc. The oldest executive at Sientra Inc is Jeffrey Nugent, 72, who is the Chairman of the Board, Chief Executive Officer.
What's Caroline Hove's mailing address?
Hove's mailing address filed with the SEC is 3333 MICHELSON DR, SUITE 650, , IRVINE, CA, 92612.
Insiders trading at Sientra Inc
Over the last 10 years, insiders at Sientra Inc have traded over 15,843,498$ worth of Sientra Inc stock and bought 1,651,210 units worth 23,354,020$ . The most active insiders traders include Llp Abingworth、Advisors Llc Orbi Med Capit...、Timothy Haines. On average, Sientra Inc executives and independent directors trade stock every 73 days with the average trade being worth of 17,193$. The most recent stock trade was executed by Ronald Menezes on 10 November 2021, trading 78,498 units of SIEN stock currently worth 445,084$.
What does Sientra Inc's logo look like?
Complete history of Ms. Van stock trades at Sientra Inc
Sientra Inc executives and stock owners
Sientra Inc executives and other stock owners filed with the SEC include:
-
Jeffrey Nugent,
Chairman of the Board, Chief Executive Officer -
Paul Little,
Chief Financial Officer, Senior Vice President, Treasurer -
Keith Sullivan,
Director -
Mary Fisher,
Independent Director -
Philippe Schaison,
Independent Director -
Nicholas Simon,
Lead Independent Director -
Kevin O'Boyle,
Independent Director -
Caroline Van Hove,
Independent Director -
R Scott Greer,
Director -
Matthew Pigeon,
CFO and Treasurer -
Hani M Zeini,
Director -
Advisors Llc Orbi Med Capit...,
-
Alexander W. Casdin,
Director -
Charles Huiner,
COO & SVP Corp. Dev. Strategy -
Patrick F. Williams,
General Manager miraDry & SVP -
Llp Abingworth,
10% owner -
Timothy Haines,
Director -
Oliver Christian Bennett,
GC & Chief Compliance Officer -
Valerie J Miller,
VP, Controller and Interim CFO -
Nori Ebersole,
Director -
Andrew C Schmidt,
Chief Financial Officer -
Irina Erenburg,
Director -
Ronald Menezes,
President and CEO